Delivery Order SPE2DB22D2006-SPE2DB24FV7BG
Award Date
12/21/23
Potential Completion Date
12/22/23
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $18,732.80 and is a delivery order with a firm fixed price. The ultimate completion date is January 24, 2024. There is no set-aside designation for this contract, indicating it...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $8,765.68, was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL pharmaceutical products to support U.S. government healthcare programs. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $18,130.94, and has an ultimate completion date of...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML to the U.S. Defense Department's Medical Supply Chain agency. The $25,835.99 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $7,174.80. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML to the Defense Logistics Agency (DLA). The $21,528.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 26, 2023 and was awarded on April 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,393.62, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The award has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract has a ceiling value of $5,288.62 and an ultimate completion date of October 24, 2023. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and it is awarded under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc. This IDC,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a Delivery Order with a Firm Fixed Price pricing type, a total ceiling value of $4,127.07, and a performance period that runs through December 28, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a firm fixed-price delivery order with a ceiling value of $2,191.87 and an ultimate completion date of September 21, 2021. This award is not designated as a set-aside and represents an open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...